Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Maiti PK, Ray A, Bandyopadhyay S, 2002. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health 7 :788–792.
-
2
Hay RJ, 2002. Fungal infections. Cook G, Zumla AI, eds. Manson’s Tropical Diseases. 21st edition. Philadelphia: W. B. Saunders, 1180–182.
-
3
Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A, 2004. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 4 :566–574.
-
4
Lacroix C, de Kerviler E, Morel P, Derouin F, Feuilhade de Chauvin M, 2005. Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol 152 :1067–1068.
-
5
Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F, Dannaoui E, 2006. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol 44 :340–349.
-
6
Mouas H, Lutsar I, Dupont B, Fain O, Herbrecht R, Lescure FX, Lortholary O, Voriconazole/Bone Invasive Aspergillosis Study Group, 2005. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis 40 :1141–1147.
-
7
Ndiaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R, 2006. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 45 :154–157.
-
8
Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A, 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47 :339–346.
-
9
Chakraborty A, Workman MR, Bullock PR, 2005. Scedosporium apiospermum brain abscess treated with surgery and voriconazole. Case report. J Neurosurg 103 :83–87.
-
10
Husain S, Munoz P, Forrest G, Alexander BD, Somani J, Brennan K, Wagener MM, Singh N, 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 40 :89–99.
-
11
Consigny S, Dhedin N, Datry A, Choquet S, Leblond V, Chosidow O, 2003. Successsful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin Infect Dis 37 :311–313.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 19 | 19 | 6 |
| Full Text Views | 530 | 251 | 1 |
| PDF Downloads | 134 | 35 | 0 |
SUCCESSFUL TREATMENT OF BLACK-GRAIN MYCETOMA WITH VORICONAZOLE
PIERRE LOULERGUE
PIERRE LOULERGUE
Centre d’Infectiologie Necker-Pasteur, et Service de Radiologie, Hôpital Necker-Enfants Malades, Université Paris V, Paris, France; Centre National de Référence Mycologie et Antifongiques, Centre National de la Recherche Scientifique FRE2849, Institut Pasteur, Paris, France; Laboratoire Parasitologie-Mycologie, Hôpital Européen Georges Pompidou, Paris, France; Service de Dermatologie, Hôpital Robert Ballanger, Aulnay sous, Bois, France
Search for other papers by PIERRE LOULERGUE in
Current site
Google Scholar
PubMed
Search for other papers by PIERRE LOULERGUE in
Current site
Google Scholar
PubMed
ARNAUD HOT
ARNAUD HOT
Centre d’Infectiologie Necker-Pasteur, et Service de Radiologie, Hôpital Necker-Enfants Malades, Université Paris V, Paris, France; Centre National de Référence Mycologie et Antifongiques, Centre National de la Recherche Scientifique FRE2849, Institut Pasteur, Paris, France; Laboratoire Parasitologie-Mycologie, Hôpital Européen Georges Pompidou, Paris, France; Service de Dermatologie, Hôpital Robert Ballanger, Aulnay sous, Bois, France
Search for other papers by ARNAUD HOT in
Current site
Google Scholar
PubMed
Search for other papers by ARNAUD HOT in
Current site
Google Scholar
PubMed
ERIC DANNAOUI
ERIC DANNAOUI
Centre d’Infectiologie Necker-Pasteur, et Service de Radiologie, Hôpital Necker-Enfants Malades, Université Paris V, Paris, France; Centre National de Référence Mycologie et Antifongiques, Centre National de la Recherche Scientifique FRE2849, Institut Pasteur, Paris, France; Laboratoire Parasitologie-Mycologie, Hôpital Européen Georges Pompidou, Paris, France; Service de Dermatologie, Hôpital Robert Ballanger, Aulnay sous, Bois, France
Search for other papers by ERIC DANNAOUI in
Current site
Google Scholar
PubMed
Search for other papers by ERIC DANNAOUI in
Current site
Google Scholar
PubMed
ALEXIANE DALLOT
ALEXIANE DALLOT
Centre d’Infectiologie Necker-Pasteur, et Service de Radiologie, Hôpital Necker-Enfants Malades, Université Paris V, Paris, France; Centre National de Référence Mycologie et Antifongiques, Centre National de la Recherche Scientifique FRE2849, Institut Pasteur, Paris, France; Laboratoire Parasitologie-Mycologie, Hôpital Européen Georges Pompidou, Paris, France; Service de Dermatologie, Hôpital Robert Ballanger, Aulnay sous, Bois, France
Search for other papers by ALEXIANE DALLOT in
Current site
Google Scholar
PubMed
Search for other papers by ALEXIANE DALLOT in
Current site
Google Scholar
PubMed
SYLVAIN POIRÉE
SYLVAIN POIRÉE
Centre d’Infectiologie Necker-Pasteur, et Service de Radiologie, Hôpital Necker-Enfants Malades, Université Paris V, Paris, France; Centre National de Référence Mycologie et Antifongiques, Centre National de la Recherche Scientifique FRE2849, Institut Pasteur, Paris, France; Laboratoire Parasitologie-Mycologie, Hôpital Européen Georges Pompidou, Paris, France; Service de Dermatologie, Hôpital Robert Ballanger, Aulnay sous, Bois, France
Search for other papers by SYLVAIN POIRÉE in
Current site
Google Scholar
PubMed
Search for other papers by SYLVAIN POIRÉE in
Current site
Google Scholar
PubMed
BERTRAND DUPONT
BERTRAND DUPONT
Centre d’Infectiologie Necker-Pasteur, et Service de Radiologie, Hôpital Necker-Enfants Malades, Université Paris V, Paris, France; Centre National de Référence Mycologie et Antifongiques, Centre National de la Recherche Scientifique FRE2849, Institut Pasteur, Paris, France; Laboratoire Parasitologie-Mycologie, Hôpital Européen Georges Pompidou, Paris, France; Service de Dermatologie, Hôpital Robert Ballanger, Aulnay sous, Bois, France
Search for other papers by BERTRAND DUPONT in
Current site
Google Scholar
PubMed
Search for other papers by BERTRAND DUPONT in
Current site
Google Scholar
PubMed
OLIVIER LORTHOLARY
OLIVIER LORTHOLARY
Centre d’Infectiologie Necker-Pasteur, et Service de Radiologie, Hôpital Necker-Enfants Malades, Université Paris V, Paris, France; Centre National de Référence Mycologie et Antifongiques, Centre National de la Recherche Scientifique FRE2849, Institut Pasteur, Paris, France; Laboratoire Parasitologie-Mycologie, Hôpital Européen Georges Pompidou, Paris, France; Service de Dermatologie, Hôpital Robert Ballanger, Aulnay sous, Bois, France
Search for other papers by OLIVIER LORTHOLARY in
Current site
Google Scholar
PubMed
Search for other papers by OLIVIER LORTHOLARY in
Current site
Google Scholar
PubMed
Fungal mycetoma (or eumycetoma) are endemic diseases in tropical areas that have economic effects because of their chronic and disabling evolution. Classic treatments include surgery and antifungal drugs, but these have multiple side effects. We report a case of black-grain fungal mycetoma successfully treated with voriconazole without side effects. The duration of the treatment remains unclear, but must be prolonged because of the frequency of relapses.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Maiti PK, Ray A, Bandyopadhyay S, 2002. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health 7 :788–792.
-
2
Hay RJ, 2002. Fungal infections. Cook G, Zumla AI, eds. Manson’s Tropical Diseases. 21st edition. Philadelphia: W. B. Saunders, 1180–182.
-
3
Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A, 2004. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 4 :566–574.
-
4
Lacroix C, de Kerviler E, Morel P, Derouin F, Feuilhade de Chauvin M, 2005. Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol 152 :1067–1068.
-
5
Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F, Dannaoui E, 2006. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol 44 :340–349.
-
6
Mouas H, Lutsar I, Dupont B, Fain O, Herbrecht R, Lescure FX, Lortholary O, Voriconazole/Bone Invasive Aspergillosis Study Group, 2005. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis 40 :1141–1147.
-
7
Ndiaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R, 2006. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 45 :154–157.
-
8
Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A, 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47 :339–346.
-
9
Chakraborty A, Workman MR, Bullock PR, 2005. Scedosporium apiospermum brain abscess treated with surgery and voriconazole. Case report. J Neurosurg 103 :83–87.
-
10
Husain S, Munoz P, Forrest G, Alexander BD, Somani J, Brennan K, Wagener MM, Singh N, 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 40 :89–99.
-
11
Consigny S, Dhedin N, Datry A, Choquet S, Leblond V, Chosidow O, 2003. Successsful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin Infect Dis 37 :311–313.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 19 | 19 | 6 |
| Full Text Views | 530 | 251 | 1 |
| PDF Downloads | 134 | 35 | 0 |